(Total Views: 157)
Posted On: 06/11/2019 8:00:49 AM
Post# of 21237

$ACHV News Article - Achieve Life Sciences Announces Statistically Significant Improvement in Quit Rates for Simplified Cytisinicline Dosing Schedule in Phase 2b ORCA-1 Dose-Selection Trial https://marketwirenews.com/news-releases/achi...35648.html


My Twitter: WhyteStocks